Lantheus Holdings (LNTH) Other financing activities (2015 - 2026)
Lantheus Holdings' (LNTH) quarterly Other financing activities came in at $2.6 million in Q1 2026, up 194.36% on a QoQ basis from -$2.7 million in Q4 2025.
Lantheus Holdings (LNTH) Other financing activities (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 12 years of Other financing activities data on file, last reported at $2.6 million in Q1 2026.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 151.11% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, up 8.03% from the prior year.
- Other financing activities for Q1 2026 stood at $2.6 million, up from -$2.7 million in the prior quarter.
- Over the last five years, Other financing activities for LNTH reached as high as $5.4 million in Q1 2022 and fell as low as -$2.7 million in Q4 2025.
- Historically, Other financing activities has averaged $1.4 million across 5 years, with a median of $1.3 million in 2023.
- Across the five-year window, Other financing activities tumbled 100.15% in 2022 and surged 35500.0% in 2023, its largest moves.
- Year by year, Other financing activities stood at -$1000.0 in 2022, then jumped by 35500.0% to $354000.0 in 2023, then surged by 173.16% to $967000.0 in 2024, then plunged by 383.97% to -$2.7 million in 2025, then jumped by 194.36% to $2.6 million in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $2.6 million in Q1 2026, -$2.7 million in Q4 2025, and $4.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | -2.75 Mn |
| Dec 31, 2025 | -2.75 Mn |
| Sep 30, 2025 | 4.49 Mn |
| Sep 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Sep 30, 2024 | 967,000.00 |
| Sep 30, 2024 | 967,000.00 |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 934,000.00 |
| Mar 31, 2024 | 934,000.00 |
| Dec 31, 2023 | 354,000.00 |
| Dec 31, 2023 | 354,000.00 |
| Sep 30, 2023 | 273,000.00 |
| Sep 30, 2023 | 273,000.00 |
| Jun 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 1.35 Mn |